Avian Dermatology

Dermatologic conditions are common in avian practice and can be caused by a huge array of potential disorders, ranging from infectious diseases, ectoparasites, metabolic disorders, nutritional deficiencies, and management deficits. The skin is the largest organ in the body and has the potential to lead to significant discomfort and welfare compromise when pathology is present. Some conditions may be relatively pathognomonic based on gross findings, whereas others may require a full diagnostic workup to investigate. Getting to the bottom of skin lesions and disorders often involves identification and correction of the underlying cause, rather than just treating the lesions present in the integument.

Medical Causes of Feather Damaging Behavior

Feather damaging behavior (FDB), also referred to as feather picking, feather plucking, or pterotillomania, is one of the most common and frustrating clinical presentations in captive psittacines. The clinical approach to identify underlying medical conditions associated with FDB is reviewed. Primary feather or skin diseases as well as systemic diseases may lead to this syndrome. This article focuses on the medical causes of FDB documented in the current avian literature. Medical causes are presented using the VITAMIN D algorithm. Key components of the multifaceted therapeutic approach in managing FDB of medical origin are discussed.

Medication for Behavior Modification in Birds

The use of behavior modifying drugs may be considered in birds with behavior problems, especially those refractory to behavior modification therapy and environmental management. To accomplish behavior change, a variety of drugs can be used, including psychoactive drugs, hormones, antihistamines, analgesics, and anticonvulsants. Because their prescription to birds is off-label, these drugs are considered appropriate only when a sound rationale can be provided for their use. This requires a (correct) behavioral diagnosis to be established. In addition, regular monitoring and follow-up are warranted to determine the efficacy of the treatment and evaluate the occurrence of potential adverse side effects.

Feather loss and feather destructive behavior in pet birds

Feather loss in psittacine birds is a common and frustrating clinical presentation. Causes include medical and nonmedical causes of feather loss with and without overt feather destructive behavior. Underlying causes include inappropriate husbandry and housing; parasitic, viral and bacterial infections; metabolic and allergic diseases; and behavioral disorders. Prior to a diagnosis of a behavioral disorder, medical causes of feather loss must be excluded through a complete medical work-up including history, physical examination, and diagnostic testing. This article focuses on common medical and nonmedical causes of feather loss and feather destructive behavior and approaches to diagnosis and treatment.

Clinical approach to dermatologic disease in exotic animals

Skin disease is an extremely common presenting complaint to the exotic animal practitioner. A systematic diagnostic approach is necessary in these cases to achieve a diagnosis and formulate an effective treatment plan. In all exotic species, husbandry plays a central role in the pathogenesis of cutaneous disease, so a thorough evaluation of the husbandry is critical for successful management. The clinical approach to skin disease in exotic animal patients is reviewed with specific focus on structure and function of the skin, diagnostic testing, and differential diagnoses for commonly encountered cutaneous diseases.

Evaluation of intravenous fluorescein in intradermal allergy testing in psittacines

This study was designed to improve the clinical feasibility of intradermal skin testing of psittacine birds using intravenous fluorescein stain. Twenty-five healthy, anaesthetized Hispaniolan Amazon parrots (Amazona ventralis) were injected intravenously with 10 mg kg-1 fluorescein-sodium 1% followed by intradermal injections of 0.02 mL phosphate-buffered saline, histamine phosphate (1:100,000 w/v) and codeine phosphate (1:100,000 w/v) at the sternal apteria. Wheal diameters of reaction sites were measured grossly and under illumination with a Wood's lamp after 5 and 10 min. Fluorescence-enhanced injection sites were scored between 0 and 2, with 0 equivalent to normal skin and 2 equivalent to a plucked feather follicle. The presence of a fluorescent halo around intradermal injections was also recorded. Under Wood's light illumination at 10 min, histamine and saline were evaluated as positive and negative controls, respectively, based on a positive test having a halo and a score of 2. Sensitivity and specificity were each 76% for halo, 84 and 42% for score and 64 and 77% for combination of score and halo, respectively. Further, mean histamine reactions were significantly larger than codeine phosphate and saline (8.8 +/- 0.4 mm; 7.2 +/- 0.3 mm; 5.9 +/- 0.6 mm); however, this finding was not consistent in individual birds. Wheal size, halo presence and score were affected by site location independent from the injected compound. Intravenous fluorescein improved the readability of avian skin tests; however, the compounds tested raised inconsistent reactions in wheal size, score or halo presence. The compound-independent site effect raises concern on the validity of avian skin testing and warrants investigation of other techniques such as in vitro allergy testing. Based on our findings, intradermal allergy testing in psittacines with or without fluorescein is unreliable and cannot be recommended for practical clinical use.